secwatch.observer — SEC 8-K summary
======================================

Issuer:     SBC Medical Group Holdings Inc (SBC)
CIK:        0001930313
Form:       8-K
Filed at:   2026-07-14T21:00:30+00:00
Accession:  0001493152-26-033195
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01, 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SBC Medical loses Nasdaq compliance after director departure; cure period granted
--------------------------------------------------------------------------------

- Director Mike Sayama did not seek re-election, leaving board with 2 of 4 independent directors and audit committee with 2 members.
- Nasdaq granted cure period until earlier of next annual meeting or July 9, 2027; company searching for a fifth independent director.
- Shareholders approved charter amendments: eliminate plurality voting, remove for-cause removal, opt out of DGCL Section 203, and officer exculpation.
- Bylaws amended to incorporate universal proxy rules, update quorum, and enhance advance notice provisions for stockholder nominations.
- All four director nominees elected with over 90 million votes each; ratification of auditor MaloneBailey approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1930313/000149315226033195/0001493152-26-033195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1930313/000149315226033195/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-033195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer